George Clinical Expands Asia-Pacific Footprint with New Location in the Philippines

SYDNEY, May 29, 2019 /PRNewswire/ — George Clinical, a global scientifically-backed clinical research organization (CRO), has again expanded its extensive Asia-Pacific footprint through the opening of a new office in the Philippines. The office is based in the capital city, Manila and compliments the organization’s growing list of global locations.

The opening of this office formalizes a long-standing strategic focus on the country and the region, by increasing investigator networks and collaborative solutions to enhance study quality, study performance and shorten start timelines. The Philippines is a strong performer in the Asian clinical trial landscape, not only due to a large cohort of treatment naïve patients, but generally good treatment adherence, and a high level of English literacy.  

“George Clinical is honoured to formalize our presence in the Philippines,” Evon Hui, Head of Business Operations, East Asia said. “We have a long standing strategic focus on building the clinical trial infrastructure in the Philippines. Through the development of this entity, George Clinical looks forward to working with sponsors to make the most of the benefits that running a clinical trial in the Philippines will provide.”

Historically, The Philippines has a particularly strong track record in the conduct of infectious diseases, oncology, metabolic disorders, respiratory and cardiovascular trials. George Clinical has an extensive track record in chronic disease trials that correlates directly with the most prevalent indications in the country.

About George Clinical

George Clinical is a leading global clinical research organization founded in Asia-Pacific driven by scientific expertise and operational excellence. With 20 years of experience and more than 300 staff managing 38 geographical locations throughout the USA, Asia-Pacific region and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration and post-marketing trials.    

Contact:          mreabold@georgeclinical.com
Website:          https://www.georgeclinical.com
LinkedIn:         https://www.linkedin.com/company/george-clinical-pty-ltd
Twitter:            https://twitter.com/george_clinical
Facebook:       https://www.facebook.com/georgeclinical

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/george-clinical-expands-asia-pacific-footprint-with-new-location-in-the-philippines-300858071.html

SOURCE George Clinical

Staff

Recent Posts

Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)

Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite"…

1 hour ago

Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design

'Beyond Structure, Predicting Function' SHANGHAI, Dec. 25, 2024 /PRNewswire/ -- Recently, Shanghai Matwings Technology Co.,…

8 hours ago

Casect Launches AI-Enhanced Case Log Platform for Surgeons

SHERIDAN, Wyo., Dec 25, 2024 /PRNewswire/ -- Casect, LLC, a medical education technology company, announces…

14 hours ago

CorVel Announces Effectiveness of Three-For-One Forward Stock Split

FORT WORTH, Texas, Dec. 24, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) today announced…

23 hours ago

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

- Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be…

23 hours ago